Immix Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Immix Biopharma, Inc. has filed 235 SEC EDGAR filings since 20 Jul 2021

SEC filing history

Showing 201-225 of 235 matching filings.

Per page
25
Current page
9
4

4 filing

Filing date
20 Dec 2021
Reporting date
20 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Dec 2021
Reporting date
20 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Dec 2021
Reporting date
20 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-259591

424B4 filing

Filing date
17 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
15 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-259591

EFFECT filing

Filing date
15 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
15 Dec 2021
Reporting date
15 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
15 Dec 2021
Reporting date
15 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
15 Dec 2021
Reporting date
15 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
15 Dec 2021
Reporting date
15 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
15 Dec 2021
Reporting date
15 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
15 Dec 2021
Reporting date
15 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
15 Dec 2021
Reporting date
15 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
15 Dec 2021
Reporting date
15 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
15 Dec 2021
Reporting date
15 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-41159

CERT filing

Filing date
14 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
13 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
13 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-41159

8-A12B filing

Filing date
13 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-259591

FWP filing

Filing date
01 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-259591

S-1/A filing

Filing date
04 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-259591

S-1/A filing

Filing date
28 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
19 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-259591

S-1/A filing

Filing date
15 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
15 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .